Published in J Aerosol Med Pulm Drug Deliv on April 01, 2010
The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future. J Aerosol Med Pulm Drug Deliv (2010) 0.96
The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation. J Aerosol Med Pulm Drug Deliv (2010) 0.87
Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system. J Aerosol Med Pulm Drug Deliv (2010) 0.78
Advances in device and formulation technologies for pulmonary drug delivery. AAPS PharmSciTech (2014) 0.77
Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika (1947) 10.31
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Compliance in asthma. Respir Med (1999) 1.44
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA. J Aerosol Med Pulm Drug Deliv (2010) 1.26
Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest (1997) 1.24
Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care (2000) 1.18
Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv (2010) 1.04
Advances in aerosols: adult respiratory disease. J Aerosol Med (2006) 1.03
Inhaler technique of outpatients in the home. Respir Care (2000) 1.02
Human variation in the peripheral air-space deposition of inhaled particles. J Appl Physiol (1985) (1987) 1.01
Parents' adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system. J Aerosol Med (2003) 0.96
Evaluation of an Auditory Feedback Equipped Metered Dose Inhaler. Am J Ther (1996) 0.81
Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma. J Allergy Clin Immunol (2009) 1.43
Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA. J Aerosol Med Pulm Drug Deliv (2010) 1.26
Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study. Respir Care (2007) 1.12
Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv (2010) 1.04
The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future. J Aerosol Med Pulm Drug Deliv (2010) 0.96
Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol (2003) 0.88
The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility. J Aerosol Med Pulm Drug Deliv (2010) 0.86
Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv (2010) 0.85
Ophthalmologic findings in children with asthma receiving inhaled budesonide. J Allergy Clin Immunol (2008) 0.84
Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks. J Aerosol Med Pulm Drug Deliv (2013) 0.84
Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med (2005) 0.84
Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res (2010) 0.83
An instrumented valved holding chamber with facemask to measure application forces and flow in young asthmatic children. J Aerosol Med Pulm Drug Deliv (2014) 0.80
Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children--not too much, not too little. Thorax (2011) 0.80
Drug delivery and adherence in young children. Pediatr Pulmonol (2004) 0.80
Challenges and opportunities in respiratory drug delivery devices. Expert Opin Drug Deliv (2010) 0.80
Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. Pediatr Res (2010) 0.76
Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma. J Aerosol Med Pulm Drug Deliv (2014) 0.76
Authorising engineer's 'pivotal role' explained. Health Estate (2011) 0.75
Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opin Drug Deliv (2015) 0.75